Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1

被引:253
|
作者
Brems, Hilde [1 ]
Beert, Eline [1 ]
de Ravel, Thomy [1 ]
Legius, Eric [1 ]
机构
[1] Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium
来源
LANCET ONCOLOGY | 2009年 / 10卷 / 05期
关键词
NERVE SHEATH TUMORS; GASTROINTESTINAL STROMAL TUMORS; VON-RECKLINGHAUSENS-DISEASE; SOUTH EAST WALES; NF1; GENE; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; INTERGROUP RHABDOMYOSARCOMA; PILOCYTIC ASTROCYTOMAS; CONSENSUS STATEMENT; RAPAMYCIN PATHWAY;
D O I
10.1016/S1470-2045(09)70033-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neurofibromatosis type 1(NF1) is a familial tumour syndrome. Malignant tumours can arise in the nervous and non-nervous system in either childhood or adulthood, with malignant peripheral nerve sheath tumours being most common. Rhabdomyosarcoma and neuroblastoma are paediatric neoplasms that are more common in children with NF1 than in those without the syndrome. Gastrointestinal stromal tumours, somatostatinomas, breast cancer, and phaeochromocytomas are seen in adults with NF1. Several pathways are thought to be involved in the development of tumours associated with NF1: rat sarcoma viral oncogene homologue (RAS)-mitogen activated protein kinase (MAPK), mammalian target of rapamycin (mTOR), and P21 protein (Cdc42/Rac)-activated kinase 1 (PAK1). New insights into the pathogenesis of these tumours will lead to a better understanding of tumour origin and development and will hopefully allow the discovery of new and specific treatments.
引用
收藏
页码:508 / 515
页数:8
相关论文
共 50 条
  • [1] Benignan and malignant tumours in patients with neurofibromatosis type 1
    Ortiz, M
    Falcó, V
    Sánchez, L
    Ruiz, E
    Cervera, C
    Alegre, J
    de Sevilla, TF
    [J]. MEDICINA CLINICA, 2001, 117 (09): : 336 - 338
  • [2] Neurofibromatosis type 1-associated tumours: Their somatic mutational spectrum and pathogenesis
    Laycock-Van Spyk S.
    Thomas N.
    Cooper D.N.
    Upadhyaya M.
    [J]. Human Genomics, 5 (6) : 623 - 690
  • [3] Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1
    Stewart, Douglas R.
    Corless, Christopher L.
    Rubin, Brian P.
    Heinrich, Michael C.
    Messiaen, Ludwine M.
    Kessler, Lisa J.
    Zhang, Paul J.
    Brooks, David G.
    [J]. JOURNAL OF MEDICAL GENETICS, 2007, 44 (01)
  • [4] Malignant peripheral nerve sheath tumours in neurofibromatosis 1
    Evans, DGR
    Baser, ME
    McGaughran, J
    Sharif, S
    Howard, E
    Moran, A
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (05) : 311 - 314
  • [5] Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma
    V. F. Mautner
    R. E. Friedrich
    A. von Deimling
    C. Hagel
    B. Korf
    M. T. Knöfel
    R. Wenzel
    C. Fünsterer
    [J]. Neuroradiology, 2003, 45 : 618 - 625
  • [6] Malignant peripheral nerve sheath tumours in neurofibromatosis type 1:: MRI supports the diagnosis of malignant plexiform neurofibroma
    Mautner, VF
    Friedrich, RE
    von Deimling, A
    Hagel, C
    Korf, B
    Knöfel, MT
    Wenzel, R
    Fünsterer, C
    [J]. NEURORADIOLOGY, 2003, 45 (09) : 618 - 625
  • [7] Neurofibromatosis type 1: brain stem tumours
    Bilaniuk, LT
    Molloy, PT
    Zimmerman, RA
    Phillips, PC
    Vaughan, SN
    Liu, GT
    Sutton, LN
    Needle, M
    [J]. NEURORADIOLOGY, 1997, 39 (09) : 642 - 653
  • [8] Neurofibromatosis type 1: brain stem tumours
    L. T. Bilaniuk
    P. T. Molloy
    R. A. Zimmerman
    P. C. Phillips
    S. N. Vaughan
    G. T. Liu
    L. N. Sutton
    M. Needle
    [J]. Neuroradiology, 1997, 39 : 642 - 653
  • [9] GENETIC AND EPIGENETIC MECHANISMS IN THE PATHOGENESIS OF NEUROFIBROMATOSIS TYPE-I
    METHENY, LJ
    CAPPIONE, AJ
    SKUSE, GR
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (06): : 753 - 760
  • [10] Malignant Tumors for Patients With Type 1 Neurofibromatosis
    Mikhaylova, S.
    Sharapova, E.
    Yurchenkova, M.
    Kozlova, V.
    Khestanov, D.
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S477 - S477